Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-07

Clinical Trial Update: Subcutaneous Route and Pharmacology of Metoclopramide [Phase 3]

View source ↗

Summary

Phase 3 trial update on subcutaneous administration and pharmacology of metoclopramide for nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoclopramide (metoclopramide)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Nausea, Vomiting | Phase 3 | Status: COMPLETED